NDC 10424-106

SyGest

Candida Parapsilosis And Penicillium Glabrum

SyGest is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Syntrion Gmbh. The primary component is Candida Parapsilosis; Penicillium Glabrum.

Product ID10424-106_273c4e0b-eba4-46bc-959c-8d8bf0e57bc3
NDC10424-106
Product TypeHuman Otc Drug
Proprietary NameSyGest
Generic NameCandida Parapsilosis And Penicillium Glabrum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-01-10
Marketing End Date2019-08-31
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSyntrion GmbH
Substance NameCANDIDA PARAPSILOSIS; PENICILLIUM GLABRUM
Active Ingredient Strength125 mg/1; mg/1
NDC Exclude FlagN

Packaging

NDC 10424-106-01

1 BOTTLE, PLASTIC in 1 CARTON (10424-106-01) > 90 TABLET in 1 BOTTLE, PLASTIC
Marketing Start Date2014-01-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10424-106-01 [10424010601]

SyGest TABLET
Marketing CategoryUNAPPROVED HOMEOPATHIC
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-01-10
Marketing End Date2019-08-31

Drug Details

Active Ingredients

IngredientStrength
CANDIDA PARAPSILOSIS125 mg/1

OpenFDA Data

SPL SET ID:3eb5384d-8a86-455f-ba6b-97ff7c7f32e9
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.